GlaxoSmithKline CEO Witty to bow out in March 2017

LONDON (Reuters) - GlaxoSmithKline said on Thursday its Chief Executive Andrew Witty would retire in 12 months time, after leading the group since 2008, prompting Britain's biggest drugmaker to start a formal search for his successor.

http://ift.tt/1PdoefV

from Reuters: Health News
via animenewspro